期刊文献+

重症肌无力患者胸腺瘤内Titin、Ryanodine受体表位表达 被引量:4

Titin and Ryanodine receptor epitopes are expressed in thymoma with myasthenia gravis patients
原文传递
导出
摘要 目的研究重症肌无力(MG)患者血清连接素抗体(Titin-ab)和 Ryanodine 受体抗体(RyR-ab)的水平,并探讨胸腺瘤内 Titin、RyR 表位的表达。方法应用 ELISA 法检测62例 MG 患者血清中 Titin-ab、RyR-ab 水平,以45例非 MG 的其他神经系统疾病患者和50名健康志愿者为对照组,采用免疫组织化学技术,对19例合并胸腺异常者[9例 MG 合并胸腺瘤(MGT)、6例 MG 合并胸腺增生(MGH)、2例 MG 合并胸腺萎缩(MGA)以及2例非 MG 胸腺癌(NMGTC)]的冰冻胸腺组织进行Titin、RyR 染色。结果 ELISA 法显示,MG 患者 Titin-ab 总阳性率为35.5%(22/62),其中以 MGT 组阳性率最高(82.3%,14/17);而 RyR-ab 阳性率为24.2%(15/62),也以 MGT 组阳性率最高(76.5%,13/17)。9例 MGT 的肿瘤上皮细胞中有7例存在 Titin 表位的膜表达和胞质内表达,有6例存在 RyR表位的膜表达;而 MGH 组、MGA 组、NMGTC 组和对照组均无阳性表达。结论 Titin-ab 和 RyR-ab 主要见于 MGT 患者。MGT 肿瘤上皮细胞存在 Titin、RyR 表位的表达。MGT 患者体内 Titin-ab 和 RyR-ab 很可能是胸腺瘤内微环境的改变激活 Titin、RyR 特异性 T 细胞,致敏 Titin、RyR 表位使其发生自身免疫反应的结果。 Objective To study the significance of Titin-ab and Ryanodine receptor-ab (RyR-ab) in the myasthenia gravis (MG) patients and the expression of Titin and RyR epitopes in thymoma of myasthenia gravis. Methods Using ELISA methods, the titer of the Titin-ab, RyR-ab in the sera of 62 patients with MG, as well as 45 cases non-MG with other neurologic disorders and 50 case of normal controls were determined,and Titin and RyR were studied with immunohistochemistry stain in the 19 samples of thymic tissues from 9 cases of MG with thymoma ( MGT), 6 cases of MG with thymic hyperplasia (MGH) , 2 cases of MG with thymic atrophy (MGA), and 2 cases of non-MG with thymic carcinoma (NMGTC). Results The positive rate of Titin-ab in MG was 35.5% (22/62), with the highest being 82.3% (14/17) in MGT group. The positive rate of RyR-ab was 24. 2% ( 15/62), the highest being 76. 5% (13/17) in MGT group. Titin receptor epitopes were expressed in the transmembrane and cytoplasm region of thymoma epithelial cells of 7 cases of MGT patients, and RyR epitopes in the transmembrane region of thymoma epithelial cells of 6 cases of MGT; but no Titin nor RyR epitopes was identified in controls and such thymic pathological patterns, as MGH, MGA, NMGTC. Conclusions Titin-ab and RyR-ab are mostly found in MGT patients ; Titin and RyR epitopes are expressed in neoplasm epithelial cells of thymoma with myasthenia gravis ; it' s a result of autoimmunization of Titin and RyR epitopes irritated by Titin and RyR specific T cells activated by the change of pathogenic microenvionment inside the thymoma.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2007年第6期391-394,共4页 Chinese Journal of Neurology
基金 山东省自然基金(Y2002C13)
关键词 重症肌无力 胸腺瘤 肌蛋白质类 蛋白激酶类 兰尼碱受体钙释放通道 抗体 Myasthenia gravis Thymoma Muscle proteins Protein kinases Ryanodine receptor calcium release clannel Antibodies
  • 相关文献

参考文献8

  • 1Romi F, Skeie GO, Aarli JA, et al. The severity of myasthenia gravis correlates with the serum concentration of Titin and Ryanodine receptor antibodies. Arch Neurol, 2000, 57: 1596- 1600.
  • 2张祥,乔健,吕传真.重症肌无力患者血清中Ryanodine受体抗体检测及其临床意义[J].中华神经科杂志,2003,36(6):436-439. 被引量:14
  • 3阎志慧,徐东,刘凡英,彭忠民,吕晓霞.重症肌无力患者血清连接素抗体与临床的关系[J].临床神经病学杂志,2005,18(6):409-411. 被引量:10
  • 4De Meis L, Hasselbach W. Aceryl phosphate as substrate for Ca^2+ take in skeletal muscle microsomes. Inhibition by alkali ions. J Biol Chemi, 1971, 246: 4759-4763.
  • 5Skeie GO, Bartoccioni E, Evoli A, et al. Ryanodine receptor antibodies are associated severe myasthenia gravis. Ner J Neurol, 1996,3 : 136-140.
  • 6Willcox N. Myasthenia gravis. Curr Opin Immunol, 1993,5 : 910- 917.
  • 7Romi F, Bo L, Skeie GO, et al. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules. J Neuroimmunol,2002, 128 : 82-89.
  • 8Mygland A, Kuwajima G, Mikoshiba K, et al. Thymomas express epitopes shared by the ryanodine receptor. J Neuroimmunol, 1995, 62 : 79 -83.

二级参考文献10

  • 1Aarli JA,Skeie GO, Mygland A,et al. Muscle striation antibodies in myasthenia gravis :diagnositic and functional significance[ J]. Ann N Y Acad Sci, 1998,841:505.
  • 2Voltz RD, Albrich WC, Nagele A, et al. Paraneoplastic myasthenia gravis : detection of anti-MGT30 ( titin ) antibc, dies predicts thymic epithelial tumor[ J]. Neurology, 1997,49: 1454.
  • 3Mygland A, Arli JA, Matre R, et al. Ryanodine receptor antibodies related to severity of thymoma-associated myasthenia gravis [ J ]. J Neurol Neurosurg Psychiatry, 1994,57:843.
  • 4Skeie GO, Freiburg A, Kolmerer B, et al. Titin transcripts in thymomas[J]. Ann N Y Acad Sci,1998,841:422.
  • 5Romi F, Skeie GO, Aarli JA, et al. The Severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies[J]. Arch Neurol,2000,57 : 1596.
  • 6Fredrik Romi,Geir Olve Skeie,Johan A. Aarli,Nils Erik Gilhus. Muscle autoantibodies in subgroups of myasthenia gravis patients[J] 2000,Journal of Neurology(5):369~375
  • 7陈向军,乔健,吕传真.重症肌无力患者血清连接素抗体的检测及其临床意义[J].中华神经科杂志,2000,33(6):335-338. 被引量:17
  • 8陈向军,吕传真,乔健,陈志明,姚亚其.肌联蛋白抗体在诊断胸腺瘤重症肌无力中的意义[J].中华医学杂志,2001,81(18):1118-1120. 被引量:7
  • 9郭秀海,吴卫平,石怀银,李向红.胸腺瘤病理分型与重症肌无力关系的研究[J].临床神经病学杂志,2002,15(3):151-153. 被引量:11
  • 10吕传真,郝中顺,乔健.重症肌无力的免疫亚型和临床特点[J].中国神经精神疾病杂志,1991,17(2):65-68. 被引量:4

共引文献19

同被引文献29

  • 1谷铣之,殷蔚伯,余子豪,等,主编.肿瘤放射治疗学[M].第4版.北京:中国协和医科大学出版社,2007:226-227.
  • 2王维生.神经病学[M].5版.北京:人民卫生出版社2004:307.
  • 3Ragheb S, Lisak RP. The thymus and myasthenia gravis[J]. Chest Surg Clinics North Am, 2001,11 (2) : 311.
  • 4Skeie GO, Aarli J A, Gilhus NE, et al. Titin and ryanodine receptor antibodies in myasthenia gravis[J]. Acta Neurol Sacnd Suppl, 2006,183(1) : 19.
  • 5Richman DP, AgiusMA. Treatment of autoimmune myasthenia gravies[J]. Neurology, 2003,61 (6) : 1652.
  • 6Vicent A, Bowen J, Newsom-Davis J, et al. Seronegative general- ized myasthenia gravis: eliniealfeatures, antibodies, and their tar- gets[J]. Lancet Neurol, 2003,2 (2) : 99.
  • 7Suzuki S,Utsugisawa K,Nagane Y,et al. Three types of striation- al antibodies in myasthenia gravis[J]. Autoimmune Dis, 2011, 740583.
  • 8Romi F, Skeie GO, Aarli JA, et al. The severity of myasthenia gra- vis correlates with the serum concentration of titin and ryanodine receptor antibodies[J]. Arch Neurol, 2000,57 (11) : 1956.
  • 9Romi F,Aarli JA,Gilhus NE. Myasthenia gravis patients with ry anodine receptor antibodies have distinctive clinical features[J]. Eur J Neurol,2007,14(6) :617.
  • 10Suzuki S, Utsugisawa K, Nagane Y, et al. Classification of myas- thenia gravis based on.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部